Karasaki T, Nagayama K, Kuwano H, Nitadori J, Sato M, Anraku M, Hosoi A, Matsushita H, Morishita Y, Kashiwabara K, Takazawa M, Ohara O, Kakimi K, Nakajima J. Immunogram for cancer-immunity cycle towards personalized immunotherapy of lung cancer. At: International Association for the Study of Lung Cancer, Chicago, IL. August 25–27, 2016. Abstr MA15.01.
Kashiwabara K, Matsuyama Y. A reasonable adaptive Simon’s two-stage design. At: 38th Annual Conference of the International Society for Clinical Biostatistics, Vigo, Spain, 9–13 July, 2017. Abstr PC2-M29.
Kashiwabara K, Matsuyama Y. An efficient adaptive sample size determination via working sequential designs for confirmatory clinical trials. At: 28th International Biometric Conference, Victoria, Canada, 10–15 July, 2016. Abstr 2465136.
Kashiwabara K, Matsuyama Y. Adaptive group sequential test without predetermination of total and group sample sizes. At: 2014 Joint Statistical Meetings, Boston, MA. August 2–7, 2014. Abstract 312721.
Ogawa K, Tomiyasu H, Suenaga M, Watanabe M, Sugano S, Motegi T, Takeuchi Y, Omi A, Goto-Koshino Y, Ohno K, Skorupski A. K, Tsujimoto H. A Gene Expression Scoring System to Predict Chemotherapy Resistance Using Novel Drug Resistance Factors in Canine Lymphoma (poster presentation). 2017 Veterinary Cancer Society Annual Conference. Portland. Oct 2017.
Nomura S, Shinozaki T, Hamada C. Comparison of several approaches to adjust overall survival (OS) for extensive crossovers in placebo-controlled randomized phase 3 trials. At: The 2017 ENAR Spring Meeting, Washington, DC, March 12-15, 2017. Abstract 6h.